» Articles » PMID: 36091783

Application of Metabolomics and Network Analysis to Reveal the Ameliorating Effect of Four Typical "hot" Property Herbs on Hypothyroidism Rats

Overview
Journal Front Pharmacol
Date 2022 Sep 12
PMID 36091783
Authors
Affiliations
Soon will be listed here.
Abstract

Herbs with a "hot" properties are frequently used to treat cold symptoms in TCM. However, the underlying mechanisms of the herbs with "hot" properties on hypothyroidism have not been investigated. This study aimed to explore four typical "hot" and "cold" property herb on hypothyroidism. Firstly, the difference efficacy between the four typical "hot" property herbs and the four typical "cold" property herbs was assessed by physical signs, thyroid function, and the metabolic profile using multivariate statistical analysis. The influence of the four typical "hot" property herbs on hypothyroidism was validated pathologically. The impact mechanism of the four typical "hot" property herbs on hypothyroidism was investigated through a metabolomics method combined with network analysis. Na/K-ATP, ACC1 enzyme, UCP-1, and the PI3K-Akt pathway were used to confirm the metabolite pathways and target-associated metabolites. The results showed that the four typical "hot" property herbs could significantly improve physical signs, thyroid function, and the metabolic profile in hypothyroidism rats, the four typical "cold" property herbs did not show any benefit. Moreover, the four typical "hot" property herbs could improve lipid metabolism, energy metabolism, and thyroid hormone levels by the PI3K-Akt signaling pathway, Ca- AMPK signaling pathways, purine metabolism, and tryptophan metabolism. Additionally, the levels of UCP-1, Na+/K + -ATP enzyme, and ACC1 were ameliorated by the four typical "hot" property herbs in hypothyroidism rats. Therefore, a metabolomics strategy combined with network analysis was successfully performed and interpreted the mechanism of the four typical "hot" property herbs on hypothyroidism based on the theory of "cold and hot" properties of TCM well.

Citing Articles

Clinical comparative efficacy and therapeutic strategies for the Hashimoto's thyroiditis: A systematic review and network meta-analysis.

Luo J, Zhou L, Sun A, Min Y, Lin Y, Han L Heliyon. 2024; 10(16):e35114.

PMID: 39247354 PMC: 11379579. DOI: 10.1016/j.heliyon.2024.e35114.


Advancing herbal medicine: enhancing product quality and safety through robust quality control practices.

Wang H, Chen Y, Wang L, Liu Q, Yang S, Wang C Front Pharmacol. 2023; 14:1265178.

PMID: 37818188 PMC: 10561302. DOI: 10.3389/fphar.2023.1265178.


Metabolomic profile of patients on levothyroxine treatment for hypothyroidism.

Benabdelkamel H, Jaber M, Dahabiyeh L, Masood A, AlMalki R, Musambil M Eur Thyroid J. 2023; 12(4).

PMID: 37343156 PMC: 10388654. DOI: 10.1530/ETJ-23-0062.

References
1.
Flynn R, Bonellie S, Jung R, MacDonald T, Morris A, Leese G . Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2009; 95(1):186-93. DOI: 10.1210/jc.2009-1625. View

2.
Pan L, Li Z, Wang Y, Zhang B, Liu G, Liu J . Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus. J Ethnopharmacol. 2020; 258:112842. DOI: 10.1016/j.jep.2020.112842. View

3.
Ahmed O, Abd El-Tawab S, Ahmed R . Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions. Int J Dev Neurosci. 2010; 28(6):437-54. DOI: 10.1016/j.ijdevneu.2010.06.007. View

4.
Feng Y, Wu Z, Zhou X, Zhou Z, Fan W . Knowledge discovery in traditional Chinese medicine: state of the art and perspectives. Artif Intell Med. 2006; 38(3):219-36. DOI: 10.1016/j.artmed.2006.07.005. View

5.
Cheng X, Wei Z, Zhang G, Shao X, Li B, Gao R . A systematic review of combinatorial treatment with warming and invigorating drugs and levothyroxine for hypothyroidism caused by Hashimoto disease. Ann Transl Med. 2017; 4(23):459. PMC: 5220024. DOI: 10.21037/atm.2016.12.16. View